W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Decision
P/0371/2022 : EMA decision of 9 September 2022 on the granting of a product specific waiver for bismuth (subcitrate) / metronidazole (benzoate) / tetracycline (hydrochloride) (EMEA-003224-PIP01-22)